HERTFORDSHIRE, England and
PITTSBURGH, March 4, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ,
TASE: MYL) today announced that the Company will present at the
Barclays Global Healthcare Conference on Tuesday, March 15, 2016, in Miami. The presentation is scheduled to begin
at 3:50 p.m. ET.
Interested parties can access a live webcast of the presentation
via the investor relations section of Mylan's Web site at
www.mylan.com/investors.
About Mylan
Mylan is a global pharmaceutical company
committed to setting new standards in healthcare. Working together
around the world to provide 7 billion people access to high quality
medicine, we innovate to satisfy unmet needs; make reliability and
service excellence a habit; do what's right, not what's easy; and
impact the future through passionate global leadership. We offer a
growing portfolio of more than 1,400 generic and branded
pharmaceuticals, including antiretroviral therapies on which nearly
50% of people being treated for HIV/AIDS in the developing world
depend. We market our products in approximately 165 countries and
territories. Our global R&D and manufacturing platform includes
more than 50 facilities, and we are one of the world's largest
producers of active pharmaceutical ingredients. Every member of our
nearly 35,000-strong workforce is dedicated to creating better
health for a better world, one person at a time. Learn more at
mylan.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mylan-to-present-at-the-barclays-global-healthcare-conference-300231017.html
SOURCE Mylan N.V.